August 12, 2024 Premier CoC HS What Lies Ahead: A Look at the Biosimilar, Infectious Diseases (pharmacists and pharmacy technicians)

CONTINUING PHARMACY EDUCATION

What Lies Ahead: A Look at the Biosimilar, Infectious Diseases and

Specialty/Oncology Drug Pipeline in 2024-2025

Speaker:

SPEAKER: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services (Continuum of Care Division), Premier Inc, Charlotte, NC

ACPE Universal Program ID# 0122-0000-24-061-H01-P-/T

1 Contact Hours [0.1 CEU]

Release Date: August 12, 2024

Expiration Date: March 12, 2025

$0.00

1.00

0.100

Knowledge

Pharmacists and Pharmacy Technicians

Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

There are 2 steps to completing this home-study CE.

Step 1: Watch the video presentation in its entirety.

Step 2: Click on "Take the Test" to complete the post-test and evaluation.

Please Note: A handout is provided. Please print it out and follow along with the audio recording.

Identify biosimilar agents that have been recently approved, rejected or currently under regulatory review.
List various reimbursement models/strategies for biosimilars.
Identify notable agents that have been recently approved, rejected, in late stages of development or under regulatory review for infectious diseases indications.
Identify specialty drugs currently under regulatory review for select indications.
List oral and parenteral oncology agents currently under regulatory review for various cancers.

Release Date: Aug 12, 2024

Credit Expiration Date: Mar 12, 2025

1.00